Similar to the protective effect of ILC3s in obesity, ILC3-derived IL-22 protects against obesity-associated NAFLD through the improvement of hepatic lipid metabolism and inhibition of palmitate-induced primary hepatocyte apoptosis [151]. The gene discussed is IL22; the disease is obesity due to melanocortin 4 receptor deficiency.